Panic Disorder

Panic disorder is an anxiety disorder characterized by recurrent, unexpected panic attacks and persistent fear about experiencing future attacks. An estimated 2.7% of U.S. adults had panic disorder in the past year, making it a significant public health concern. While panic attacks can be frightening and disruptive, effective treatments are available that can help individuals manage symptoms and improve their quality of life. Research on this condition, dating back nearly 50 years, has shown that cognitive behavioral therapy (CBT) and some medications such as selective serotonin reuptake inhibitors (SSRIs) can ease panic disorder.

The impact of panic disorder extends beyond the panic attacks themselves. An estimated 4.7% of U.S. adults experience panic disorder at some time in their lives, and many individuals develop significant functional impairment. Understanding panic disorder, its symptoms, and available treatments is crucial for those affected and their loved ones. With proper treatment and support, individuals with panic disorder can learn to manage their symptoms effectively and lead fulfilling lives.

Table of Contents

• Understanding Panic Attacks
• Understanding Panic Disorder
• The Relationship Between Panic Disorder and Agoraphobia
• Why Is Panic Disorder Concerning?
• Treatment for Panic Attacks and Panic Disorder
• Coping with a Panic Attack
• Frequently Asked Questions
• How Therapy Can Help

Understanding Panic Attacks

A panic attack is defined by the rapid onset of intense fear (typically peaking within about 10 minutes) with at least four of the physical and psychological symptoms in the DSM-5 diagnostic criteria. Panic attacks typically last several minutes or sometimes longer, generally ranging from 5 to 30 minutes, though residual effects may persist longer.

Panic disorder (PD) is marked by panic attacks, which involve a sudden onset of fear, accompanied by cardiorespiratory (palpitations, dyspnea), gastrointestinal, otoneurological (dizziness), or autonomic symptoms (sweating, blushing), along with catastrophic thoughts (concerns with heart attacks, strokes, or impending doom). These attacks are unpredictable and can occur without warning, often leaving individuals feeling helpless and out of control.

Common Symptoms of Panic Attacks

During a panic attack, individuals may experience:

Physical symptoms:

• Racing heart, heart palpitations, or chest pain
• Shortness of breath or choking sensations
• Trembling or shaking
• Sweating
• Nausea or abdominal distress
• Dizziness, lightheadedness, or feeling faint
• Numbness or tingling sensations
• Chills or hot flashes

Psychological symptoms:

• Intense fear of dying
• Fear of losing control or "going crazy"
• Feeling detached from reality (derealization)
• Feeling detached from oneself (depersonalization)
• Overwhelming sense of doom

Prevalence and Causes

Panic attacks are common, affecting as much as 11% of the population in a single year. Up to 11% of people in the United States experience a panic attack every year, though not everyone who has a panic attack has panic disorder.

The exact causes of panic attacks remain unclear, but research suggests several contributing factors:

• Genetic predisposition: Some individuals may have a biological vulnerability to panic
• Environmental stressors: Major life changes, trauma, or chronic stress can trigger attacks
• Medical conditions: Thyroid problems, heart conditions, and respiratory disorders
• Substance use: According to the Substance Abuse and Mental Health Services Administration (SAMHSA), having a drug use disorder is linked to a 1 to 1.3 times higher likelihood of developing a panic disorder. As per mentalhealth.com, approximately 30% of individuals with panic disorder misuse alcohol, while 17% turn to drugs like cocaine and marijuana in unsuccessful efforts to relieve the distress and anguish caused by their condition.

Understanding Panic Disorder

Panic disorder develops when panic attacks become recurrent and when individuals develop persistent worry about future attacks. According to the DSM-5-TR, a diagnosis of panic disorder requires:

1. Recurrent unexpected panic attacks

2. At least one month of one or more of the following:- Persistent concern or worry about additional panic attacks or their consequences- A significant maladaptive change in behavior related to the attacks (e.g., behaviors designed to avoid having panic attacks, such as avoidance of exercise or unfamiliar situations)

Demographics and Onset

Past year prevalence of panic disorder among adults was higher for females (3.8%) than for males (1.6%). The disorder typically begins in late adolescence or early adulthood, with panic disorder usually beginning in late adolescence or early adulthood and affecting women about 2 times more often than men.

Among adolescents, an estimated 2.3% of adolescents had panic disorder, and 2.3% had severe impairment. The condition affects young people across all age groups, with the prevalence of panic disorder among adolescents being higher for females (2.6%) than for males (2.0%).

Severity and Impairment

Of adults with panic disorder in the past year, degree of impairment ranged from mild to serious. Impairment was distributed evenly among adults with panic disorder. An estimated 44.8% had serious impairment, 29.5% had moderate impairment, and 25.7% had mild impairment. This distribution of severity underscores the variable nature of the disorder and the importance of individualized treatment approaches.

The Relationship Between Panic Disorder and Agoraphobia

In the DSM, 5th ed., Text Revision (DSM-5-TR), agoraphobia and panic disorder are no longer linked, and agoraphobia is diagnosed independently of panic disorder. This change reflects research indicating that many individuals with agoraphobia do not experience panic disorder.

Agoraphobia is characterized by intense fear or anxiety about situations where escape might be difficult or help unavailable. Common feared situations include:

• Using public transportation
• Being in open spaces
• Being in enclosed places
• Standing in line or being in crowds
• Being outside the home alone

The DSM-5-TR notes that approximately 90% of individuals with agoraphobia have comorbid mental health conditions, such as other anxiety disorders, depressive disorders, posttraumatic stress disorder, or alcohol use disorder. While panic disorder and agoraphobia often co-occur, they are now recognized as distinct conditions that can exist independently.

Clinical Implications of Comorbidity

Previous studies also showed that agoraphobia was related to the severity of panic attacks, distress and poor functional outcome, and the findings suggested that agoraphobia could be a marker of severely aggravated panic disorder. When both conditions are present, individuals often experience:

• More severe symptoms overall
• Greater functional impairment
• Increased need for comprehensive treatment approaches
• Higher likelihood of requiring medication augmentation

Why Is Panic Disorder Concerning?

Panic disorder significantly impacts multiple areas of life and is associated with various health risks:

Mental Health Comorbidities

Panic disorder is often accompanied by at least one other comorbid condition. Other anxiety disorders, major depression, bipolar disorder, and mild alcohol use disorder are the most common psychiatric comorbidities. Common comorbid medical conditions include cardiac arrhythmias, hyperthyroidism, asthma, and chronic obstructive pulmonary disease (COPD).

In the 2006 U.S. National Comorbidity Survey of adults aged 15 to 54, 37% of individuals with panic disorder had a lifetime history of major depression. This high rate of comorbidity underscores the importance of comprehensive assessment and treatment.

Physical Health Consequences

Researchers found a significant association between panic disorder and an increased risk of developing coronary heart disease with an adjusted hazard ratio of 1.47. Individuals with panic disorder had a higher likelihood of death from coronary heart disease or myocardial infarction, with an adjusted hazard ratio of 1.4.

Simon, Naomi et al.'s 2005 study indicates that approximately 25% of individuals with chronic obstructive pulmonary disease (COPD) and around 20% of those with asthma also have a diagnosis of panic disorder.

Suicide Risk

About 15% of individuals with agoraphobia experience suicidal thoughts or behavior. Additionally, about 15% of individuals with agoraphobia report experiencing suicidal thoughts or behaviors. In Lepine, J. et al.'s 1993 study, researchers found that 42% of the 100 sample outpatients had a history of suicide attempts. 31 of the attempts (73.8%) occurred after the patient's first panic attack, while 27 attempts (64.3%) happened following the onset of panic disorder.

Quality of Life Impact

Without treatment, panic disorder can lead to:

• Social isolation and relationship difficulties
• Educational or occupational impairment
• Financial difficulties
• Reduced engagement in leisure activities
• Development of substance use disorders as self-medication
• Overall decreased quality of life

Treatment for Panic Attacks and Panic Disorder

Effective treatments are available for panic disorder, with research supporting both psychological and pharmacological interventions. CBT is the first-line psychological treatment for panic disorder. There is well-replicated evidence for short- and long-term effectiveness of CBT.

Cognitive-Behavioral Therapy (CBT)

Our findings are clear in that there are no efficacy differences between CBT delivered as guided self-help, or in the face-to-face individual or group format in the treatment of panic disorder. CBT for panic disorder typically includes:

Core Components:

• Psychoeducation: Understanding the nature of panic and anxiety
• Cognitive restructuring: Identifying and challenging catastrophic thoughts
• Interoceptive exposure: Deliberate exposure to feared bodily sensations
• In vivo exposure: Gradual confrontation of avoided situations
• Relapse prevention: Developing long-term coping strategies

A recent component network meta-analysis reviewed 72 studies to disentangle the effects of components of CBT and reported that cognitive restructuring, interoceptive exposure, and face-to-face setting were associated with better efficacy and acceptability, while muscle relaxation, breathing retraining, in vivo exposure, and virtual reality exposure (VRE) were associated with lower efficacy.

Treatment Duration and Intensity

A typical CBT course for panic disorder might run 9 to 12 weeks, but there are shorter, more intensive options as well. The Bergen 4-Day treatment for panic disorder is a concentrated CBT method developed in Norway that was first used for obsessive-compulsive disorder but has also proven effective for panic. It begins with psychoeducation in a group setting and first focuses on establishing the patient's intentions to lean into their discomfort.

Medication Options

While CBT is typically the first-line psychotherapy for panic disorder, SSRIs and serotonin-norepinephrine reuptake inhibitors (SNRIs) are also effective. The research shows that medications work faster than CBT at reducing panic attacks, though CBT is more effective over time.

Common medications include:

• SSRIs: Escitalopram, sertraline, paroxetine
• SNRIs: Venlafaxine, duloxetine
• Benzodiazepines: Used short-term for acute anxiety (with caution due to dependence risk)

Pharmacological interventions, antidepressants in particular, and CBT appear to be equally efficacious in the treatment of panic disorder.

Long-Term Outcomes

A long-term follow-up study of panic disorder patients treated with CBT reported a relapse rate of 23% over 2–14 years of follow-up period. This relatively low relapse rate highlights the enduring benefits of CBT treatment.

Studies have shown that CBT is one of the most effective treatments for panic disorder, with long-term success rates higher than medication alone. Individuals receiving CBT often report fewer panic attacks and reduced anxiety about experiencing future attacks.

Coping with a Panic Attack

When experiencing a panic attack, several strategies can help manage symptoms:

Immediate Coping Strategies

1. Focus on breathing: Practice slow, deep breathing from the diaphragm

2. Ground yourself: Use the 5-4-3-2-1 technique (identify 5 things you see, 4 you can touch, 3 you can hear, 2 you can smell, 1 you can taste)

3. Challenge catastrophic thoughts: Remind yourself that panic attacks are not dangerous

4. Find a safe space: If possible, move to a quiet, private area

5. Use progressive muscle relaxation: Systematically tense and release muscle groups

Long-Term Management

• Regular exercise: Physical activity can reduce overall anxiety levels
• Sleep hygiene: Maintain consistent sleep patterns
• Limit caffeine and alcohol: These substances can trigger or worsen panic
• Stress management: Practice meditation, yoga, or other relaxation techniques
• Build a support network: Connect with understanding friends, family, or support groups

According to Raffa, Susan et al.'s 2004 study, 90% of adults with panic disorder reported experiencing 1-4 feared consequences during a panic attack. The most frequently reported fears included embarrassment, death, fainting, losing control, going crazy, and an inability to cope or loss of independence.

Frequently Asked Questions

What is the difference between a panic attack and panic disorder?

A panic attack is a single episode of intense fear with physical symptoms that peaks within minutes. Panic disorder is diagnosed when someone has recurrent panic attacks and develops persistent worry about having more attacks for at least one month, often leading to behavioral changes to avoid triggers.

Can panic disorder be cured?

While there's no definitive "cure," panic disorder is highly treatable. Many people achieve complete remission of symptoms with proper treatment. Cognitive-behavior therapy is the most supported treatment for panic disorder. With treatment, most individuals learn to manage their symptoms effectively and lead normal lives.

How common is panic disorder in adolescents?

Panic disorder affects a significant portion of the U.S. population and has lifetime prevalence rates ranging from 2% to 6%. Adolescents aged 13-18 experience a 2.3% prevalence rate, with the prevalence being higher among females. Among adolescents with panic disorder who participated in the National Comorbidity Survey Adolescent Supplement (NCS-A), 44.8% experienced severe symptoms, while 29.5% had moderate symptoms, and 25.7% had mild symptoms.

What triggers panic attacks?

Panic attacks can be triggered by specific situations, stress, caffeine, physical sensations, or they may occur unexpectedly without an identifiable trigger. Common triggers include crowded spaces, driving, physical exertion, or reminders of previous panic attacks. Some people also experience nocturnal panic attacks that wake them from sleep.

Is medication necessary for treating panic disorder?

Medication is not always necessary. There is no high-quality, unequivocal evidence to support one psychological therapy over the others for the treatment of panic disorder with or without agoraphobia in adults. However, the results show that CBT - the most extensively studied among the included psychological therapies - was often superior to other therapies, although the effect size was small and the level of precision was often insufficient or clinically irrelevant. Many individuals respond well to CBT alone. The decision to use medication should be made in consultation with a healthcare provider based on symptom severity, individual preferences, and treatment response.

Can children develop panic disorder?

Yes, children and adolescents can develop panic disorder, though it's less common than in adults. Early intervention is particularly important for young people, as it can prevent the development of additional anxiety disorders and improve long-term outcomes. Family involvement in treatment is often beneficial for younger patients.

How Therapy Can Help

Professional treatment can make a significant difference for individuals with panic disorder. Therapists specializing in anxiety disorders can provide evidence-based treatments tailored to each person's specific needs and circumstances.

Benefits of seeking therapy include:

• Learning effective coping strategies
• Understanding and managing triggers
• Reducing avoidance behaviors
• Improving overall quality of life
• Preventing the development of additional mental health conditions
• Building resilience and confidence

If you or someone you know is struggling with panic attacks or panic disorder, consider reaching out to a qualified mental health professional. The GoodTherapy directory can help you find therapists in your area who specialize in treating anxiety and panic disorders.

Early intervention and appropriate treatment can prevent panic disorder from significantly impacting your life. With the right support and treatment approach, recovery is not just possible—it's probable.

References:

1. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
2. American Psychological Association. (2025). Short, intensive cognitive behavioral therapy can ease panic disorder. Monitor on Psychology, 56(11-12). Retrieved from https://www.apa.org/monitor/2025/11-12/panic-disorder-treatment-progress
3. Aaron, R. V., Ravyts, S. G., Carnahan, N. D., Bhattiprolu, K., & Finan, P. H. (2025). Prevalence of depression and anxiety among adults with chronic pain: A systematic review and meta-analysis. JAMA Network Open, 8(3), e250268. https://doi.org/10.1001/jamanetworkopen.2025.0268
4. Anxiety & Depression Association of America (ADAA). (2024). Understanding panic disorder. Retrieved from https://adaa.org/understanding-anxiety/panic-disorder
5. Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., Malizia, A., McCrone, P., Nabarro, D., O'Neill, C., Scott, J., van der Wee, N., & Wittchen, H. U. (2024). Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology, 38(1), 3-37. https://doi.org/10.1177/0269881124832996
6. Carl, E., Witcraft, S. M., Kauffman, B. Y., Gillespie, E. M., Becker, E. S., Cuijpers, P., van Ameringen, M., Smits, J. A. J., & Powers, M. B. (2020). Psychological and pharmacological treatments for generalized anxiety disorder (GAD): A meta-analysis of randomized controlled trials. Cognitive Behaviour Therapy, 49(1), 1-21. https://doi.org/10.1080/16506073.2018.1560358
7. Centers for Disease Control and Prevention (CDC). (2024, November 7). Symptoms of anxiety and depression among adults: United States, 2019 and 2022. National Health Statistics Reports, Number 213. Retrieved from https://www.cdc.gov/nchs/data/nhsr/nhsr213.pdf
8. Cheng, S. K., & Dizon, J. (2022). Psychosocial treatment for panic disorder: An umbrella review of systematic reviews and meta-analyses. Journal of Anxiety Disorders, 85, Article 102509. https://doi.org/10.1016/j.janxdis.2021.102509
9. Craske, M. G., Stein, M. B., Eley, T. C., Milad, M. R., Holmes, A., Rapee, R. M., & Wittchen, H. U. (2023). Panic disorder. Nature Reviews Disease Primers, 9(1), 32. https://doi.org/10.1038/s41572-023-00444-3
10. Davis, A. (2023). Panic disorder: An overview. In Brain Facts (8th ed.). Society for Neuroscience. Retrieved from https://www.brainfacts.org/diseases-and-disorders/mental-health/2023/panic-disorder
11. Fourtounas, A., Thomas, S., Yung, A. R., & Jung, H. (2023). A comparison of symptom structure between panic disorder with and without comorbid agoraphobia using network analysis. Yonsei Medical Journal, 66(5), 421-431. https://doi.org/10.3349/ymj.2025.66.5.421
12. Jung, H. W., Jang, K. W., Nam, S., Kim, A., Lee, J., Ahn, M. E., Lee, S. K., Kim, Y. J., Shin, J. K., & Roh, D. (2025). Digital cognitive behavioral therapy for panic disorder and agoraphobia: A meta-analytic review of clinical components to maximize efficacy. Journal of Clinical Medicine, 14(5), 1771. https://doi.org/10.3390/jcm14051771
13. Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group. (2024). Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry, 14(Suppl 1), S1. https://doi.org/10.1186/1471-244X-14-S1-S1
14. National Alliance on Mental Illness (NAMI). (2025). Mental health by the numbers. Retrieved from https://www.nami.org/about-mental-illness/mental-health-by-the-numbers/
15. National Institute of Mental Health (NIMH). (2024). Anxiety disorders. Retrieved from https://www.nimh.nih.gov/health/topics/anxiety-disorders
16. National Institute of Mental Health (NIMH). (2024). Panic disorder. Retrieved from https://www.nimh.nih.gov/health/statistics/panic-disorder
17. Oh, H., Do, H., Maeng, C., Park, J., Yoon, T., Kim, J., Hwang, H., Choi, S., & Huilin, P. (2025). Panic attack prediction for patients with panic disorder via machine learning and wearable electrocardiography monitoring: Model development and validation study. Journal of Medical Internet Research, 27, e54062. https://doi.org/10.2196/54062
18. Papola, D., Miguel, C., Mazzaglia, M., Franco, P., Tedeschi, F., Romero, S. A., Patel, A. R., Ostuzzi, G., Gastaldon, C., Karyotaki, E., Harrer, M., Purgato, M., Sijbrandij, M., Patel, V., Furukawa, T. A., Cuijpers, P., & Barbui, C. (2023). CBT treatment delivery formats for panic disorder: A systematic review and network meta-analysis of randomised controlled trials. Psychological Medicine, 53(3), 1060-1073. https://doi.org/10.1017/S0033291722003683
19. Papola, D., Ostuzzi, G., Tedeschi, F., Gastaldon, C., Purgato, M., Del Giovane, C., Pompoli, A., Pauley, D., Karyotaki, E., Sijbrandij, M., Furukawa, T. A., Cuijpers, P., & Barbui, C. (2022). Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: Systematic review and network meta-analysis of randomised controlled trials. The British Journal of Psychiatry, 221(3), 507-519. https://doi.org/10.1192/bjp.2021.148
20. Roy-Byrne, P. P., & Craske, M. G. (2023). Clinical practice guidelines for cognitive-behavioral therapies in anxiety disorders and obsessive-compulsive and related disorders. Indian Journal of Psychiatry, 65(2), 136-145. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_764_22
21. Substance Abuse and Mental Health Services Administration (SAMHSA). (2020). Panic disorder and agoraphobia criteria changes from DSM-IV to DSM-5. In Impact of the DSM-IV to DSM-5 changes on the National Survey on Drug Use and Health. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t10/
22. Substance Abuse and Mental Health Services Administration (SAMHSA). (2024). Release of the 2024 National Survey on Drug Use and Health: Leveraging the latest substance use and mental health data to make America healthy again. Retrieved from https://www.samhsa.gov/blog/release-2024-nsduh-leveraging-latest-substance-use-mental-health-data-make-america-healthy-again
23. Xue, H., Zhu, H., Wang, X., Yang, Y., Wang, D., & Zhao, G. (2021). Comparative efficacy and acceptability of antidepressants and benzodiazepines for the treatment of panic disorder: A systematic review and network meta-analysis. Neuropsychiatric Disease and Treatment, 17, 1363-1374. https://doi.org/10.2147/NDT.S307098